Award of cytosorbents DHA sbir PH III MED r & d contract for "integrating isoagglutinin reduction for a universal dried plasma product for battlefield and first responder use"
Active Definitive Contract Awarded Last action
- Contract number
- W81XWH22C0046
- Awardee
-
Cytosorbents Medical Inc. UEI LSF2KFUSY4K7 Part of Cytosorbents Corporation
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,292,641
Award facts
- Contract value 100% obligated
- $4,292,641.00 Current and potential, with all options
- Completion date 96% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $4,292,641 |
About this award
The Defense Health Agency's Medical Command awarded a $4.29 million definitive contract to Cytosorbents Medical Inc. for medical research and development on August 22, 2026, under a total small business set-aside. The contract is firm fixed price with an ultimate completion date of December 21, 2026.
The award funds Phase III SBIR work to develop an integrated isoagglutinin reduction technology for a universal dried plasma product intended for battlefield and first responder use. Place of performance is Monmouth Junction, South Brunswick Township, NJ.
Quick answers
Who was awarded contract W81XWH22C0046?
W81XWH22C0046 was awarded to Cytosorbents Medical Inc. by Defense Health Agency (Department of Defense) on August 22, 2022.
How much is contract W81XWH22C0046 worth?
The government has obligated $4,292,641 on W81XWH22C0046.
Which agency awarded contract W81XWH22C0046?
Defense Health Agency (Department of Defense) awarded W81XWH22C0046, with funding from Medical Command (Department of the Army).
Was contract W81XWH22C0046 competed?
The extent of competition for W81XWH22C0046 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award